21,025 results on '"Leiomyosarcoma"'
Search Results
2. Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
3. FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study (FUCHSia)
4. Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working
5. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) (SUNRISELMS)
6. A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
7. Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
8. NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
9. Metastatic Leiomyosarcoma Biomarker Protocol
10. Localized Leiomyosarcoma Biomarker Protocol
11. Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
12. Pazopanib vs. Pazopanib Plus Gemcitabine (PazoDoble)
13. Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
14. Lurbinectedin + Doxorubicin In Leiomyosarcoma
15. A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
16. A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma (TTI-621-03)
17. A Study of Nivolumab in Selected Uterine Cancer Patients
18. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2)
19. Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
20. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
21. Nanatinostat Plus Valganciclovir in Patients With Advanced EBV+ Solid Tumors, and in Combination With Pembrolizumab in EBV+ RM-NPC
22. Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma
23. A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
24. A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
25. Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors (DAPPER)
26. A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
27. Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc)
28. Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
29. CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
30. Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
31. MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
32. Letrozole in Uterine Leiomyosarcoma
33. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
34. Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
35. Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) (APROMISS)
36. Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
37. Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 (SAMHY2)
38. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)
39. Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
40. Leiomyosarcoma of vascular origin: lessons learned from misdiagnosis.
41. Challenges in Diagnosing Metastatic Uterine PEComa: Insights from Two Case Studies.
42. Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma.
43. Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver.
44. Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study.
45. Surgical and oncologic approach to leiomyosarcoma of the inferior vena cava: A case report.
46. A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.
47. Primary leiomyosarcoma of epididymis: a case report.
48. Atypical 18 F-FDG PET-CT Findings in a Rare Case of Primary Hepatic Leiomyosarcoma.
49. Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin Cancers.
50. Canine primary ureteral leiomyosarcoma treated with unilateral left ureteronephrectomy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.